Head Office Novartis International AG CH-4002 Basel Switzerland
+41 61 324 11 11 +41 61 324 80 01 Monday - Friday, 8:30 - 17:00, GMT+1 (Central European Time)
More information
Novartis International AG Investor Relations P.O. Box CH-4002 Basel Switzerland
+41 61 324 79 44 investor.relations@novartis.com
Global Media Relations Eric Althoff Basel, Switzerland
+41 61 324 7999 eric.althoff@novartis.com
Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.
Reporting side effects
Novartis provides the following information on the Group's strong financial performance since its creation in 1996.
View recent and archived annual results. »
View recent and archived quarterly results. »
Use the SEC’s EDGAR system to search and review all US disclosure filings by Novartis. »
View sales data of major Novartis products by disease area. »
Find quarterly data on foreign exchange rates for selected currencies compared to the US dollar, the Group's reporting currency. »
New investors
Clinical pipeline
Company fact sheet
Management bios
Novartis - Our next phase of growth (0.6 MB)
Turning R&D excellence into commercial success (2.0 MB)
Corporate organizational structure (41 KB)
Stock performance
Novartis announced its results for the first quarter of 2013 on April 24 ›